Science Explorer Interactive view Map
Company · Fuzhou · China

Berry Oncology (China)

Research works
111
▲ 193% vs 2013–17
Citations
2.4k
21.9 per fractional work
Top-10% rate
26.2%
record average 16.5%
Open access
61%
world 28%

Not ranked overall: Berry Oncology (China) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 1.03× its world share, 3 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 6.55× its world share, 18 worksBiochemistry, Geneti…Immunology and Microbiology: 0.85× its world share, 0 worksImmunology and Micro…Neuroscience: 2.29× its world share, 2 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 2.40× its world share, 0 worksPharmacology, Toxico…Computer Science: 0.11× its world share, 0 worksComputer ScienceEarth and Planetary Sciences: 0.49× its world share, 0 worksEarth and Planetary …Engineering: 0.15× its world share, 1 worksEngineeringEnvironmental Science: 0.17× its world share, 0 worksEnvironmental SciencePhysics and Astronomy: 0.14× its world share, 0 worksPhysics and AstronomyMedicine: 2.48× its world share, 25 worksMedicineNursing: 1.94× its world share, 0 worksNursingSocial Sciences: 0.08× its world share, 0 worksSocial Sciencesworld share
more than its size predictsabout as predictedless

Rings at 0.5×, and 2×. Widest outward: Biochemistry, Genetics and Molecular Biology, 6.5×. Every wedge is a field page.

Which keywords describe research at Berry Oncology (China)?

By fractional works in 2022–2025, weighted toward what it does more of than the world: Targeted Therapy, Genetic Variants, Anemia, Sickle-cell Disease, Thalassemia, Clinical Genomics, Sequence Interpretation and Cell-Free DNA.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Epidemiology6▲ 2.7×12 topics
  2. Targeted Therapy5▲ 44×3 topics
  3. Genetic Variants5▲ 51×5 topics
  4. Anemia4▲ 87×3 topics
  5. Sickle-cell Disease4▲ 184×1 topic
  6. Thalassemia4▲ 184×1 topic
  7. Cell-Free DNA4▲ 69×2 topics
  8. Clinical Genomics4▲ 200×1 topic
  9. Sequence Interpretation4▲ 200×1 topic
  10. Pancreatic Cancer3▲ 54×3 topics
  11. Clinical Trials3▲ 8.6×3 topics
  12. Chemotherapy3▲ 7.8×11 topics
  13. Alloimmunization3▲ 208×1 topic
  14. Blood Groups3▲ 208×1 topic
  15. Oxidative Stress2▲ 2.9×8 topics
  16. Genomic Instability2▲ 41×2 topics
  17. ALK Inhibitors2▲ 68×1 topic
  18. Cancer Genomics2▲ 58×1 topic
  19. EGFR Mutations2▲ 68×1 topic
  20. Inflammation2▲ 2.0×10 topics
  21. Mutational Signatures2▲ 58×1 topic
  22. Prenatal Diagnosis2▲ 26×3 topics
  23. Gene Expression2▲ 6.1×11 topics
  24. Cancer2▲ 2.5×11 topics
  25. Iron Deficiency2▲ 61×2 topics
  26. Tumor Microenvironment2▲ 7.4×5 topics
  27. Erythropoiesis2▲ 49×2 topics
  28. Genetic Mutations2▲ 7.2×7 topics
  29. Hepcidin2▲ 73×1 topic
  30. Iron Regulation2▲ 73×1 topic
  31. Aneuploidy Screening1▲ 100×1 topic
  32. Genomic Sequencing1▲ 23×2 topics
  33. Maternal Plasma DNA Sequencing1▲ 100×1 topic
  34. Prognostic Factors1▲ 5.9×7 topics
  35. Breast Cancer1▲ 10.0×3 topics
  36. Immunotherapy1▲ 3.2×3 topics
  37. Biomarkers1▲ 3.0×6 topics
  38. Cancer Progression1▲ 12×3 topics
  39. Cancer Risk1▲ 8.8×2 topics
  40. Genetic Testing1▲ 17×2 topics

Which research topics does Berry Oncology (China) publish most on?

By volume in 2022–2025: Hemoglobinopathies and Related Disorders, Genomics and Rare Diseases, Blood groups and transfusion and Lung Cancer Treatments and Mutations.

  1. 1 Hemoglobinopathies and Related Disorders Genetics 4 works
  2. 2 Genomics and Rare Diseases Genetics 4 works
  3. 3 Blood groups and transfusion Hematology 3 works
  4. 4 Lung Cancer Treatments and Mutations Pulmonary and Respiratory Medicine 2 works
  5. 5 Cancer Genomics and Diagnostics Cancer Research 2 works
  6. 6 Iron Metabolism and Disorders Hematology 2 works
  7. 7 Prenatal Screening and Diagnostics Pediatrics, Perinatology and Child Health 1 works
  8. 8 RNA modifications and cancer Molecular Biology 1 works
  9. 9 Genomic variations and chromosomal abnormalities Genetics 1 works
  10. 10 Cancer Immunotherapy and Biomarkers Oncology 1 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available60.7%not open39.3%

World: 28% of research is openly available.

with international co-authors19.2%domestic only80.8%

World: 19% is written across borders.

How has Berry Oncology (China)'s research output changed?

Output in 2018–2022 was 193% higher than in 2013–2017.

1990200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Fuzhou

All research institutions in Fuzhou

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.